Reuters logo
a month ago
BRIEF-Sorrento Therapeutics' pain subsidiary announces positive data with lead product
June 14, 2017 / 1:42 PM / a month ago

BRIEF-Sorrento Therapeutics' pain subsidiary announces positive data with lead product

1 Min Read

June 14 (Reuters) - Sorrento Therapeutics Inc

* Sorrento Therapeutics' pain subsidiary, Scilex Pharmaceuticals, announces positive data from head to head adhesion study with its lead product, ZTlido

* Sorrento Therapeutics- ‍plans to resubmit NDA for ZTlido to FDA and MAA to MHRA in U.K., and other member states (EU countries) in second half of 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below